Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. [11-20-2013] The U.S. Food and Drug Administration (FDA) is warning health care professionals of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress...

  2. Lexiscan is a prescription drug given through an IV line that increases blood flow through the arteries of the heart during a cardiac nuclear stress test. Lexiscan is given to patients when they are unable to exercise adequately for a stress test. Important Safety Information.

  3. 11 Δεκ 2014 · The FDA warned health care professionals of a “rare but serious risk of heart attack and death” associated with use of regadenoson (Lexiscan) and adenosine (Adenoscan). The drugs’ labels are being updated to reflect the risk and revised recommendations for use.

  4. 2 Νοε 2024 · Lexiscan also known as regadenoson, a pharmacological stressor for cardiac stress test. Cardiolite (Technetium Tc-99m sestamibi) is a radioactive tracer for the assessment of the blood flow during cardiac stress test. Cardiolite 1-day protocol: resting first with 10 mCi Tc99, then do 0.4 mg Lexiscan (regadenoson) + 30 mCi Tc99 test. 16.

  5. symptoms or signs suggestive of coronary artery disease (CAD) such as chest pain, shortness of breath. significant risk factors for CAD such as smoking, high blood pressure, high cholesterol. assessment of your condition after a cardiac procedure such as bypass surgery or coronary angioplasty.

  6. 22 Νοε 2013 · The U.S. Food and Drug Administration has issued a warning that there is a rare but serious risk of heart attack or death associated with the use of cardiac nuclear stress test agents...

  7. There are several reasons you may be asked to have a stress test with Cardiolite®: SUSPECTS YOU MAY HAVE HEART DISEASE AND WANTS TO CONFIRM IT. Your doctor may suspect coronary. artery disease if you have chest pressure or other symptoms. Having certain risk factors such as high blood pressure or family history of heart disease could.

  1. Γίνεται επίσης αναζήτηση για